Serial Success With Triumvira's Rob Williamson
Business Of Biotech
Innovative Therapy Approaches and Evolving Priorities in Cancer Treatment
The chapter explores a novel therapy targeting Glottin 18-2 for gastric and gastroesophageal tumors, highlighting its positive outcomes and focus on safety for redosing and outpatient use. It delves into the challenges of gene editing precision in therapeutic interventions and expresses optimism for progressing companies in this field. Additionally, the chapter discusses the shift in attitudes towards investment risks in biotech partnerships, emphasizing the importance of strategic decisions and creating lasting value in the industry.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
